A systematic review to investigate the measurement properties of goal attainment scaling, towards use in drug trials

BACKGROUND: One of the main challenges for drug evaluation in rare diseases is the often heterogeneous course of these diseases. Traditional outcome measures may not be applicable for all patients, when they are in different stages of their disease. For instance, in Duchenne Muscular Dystrophy, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaasterland, Charlotte M. W., Jansen-van der Weide, Marijke C., Weinreich, Stephanie S., van der Lee, Johanna H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4989379/
https://www.ncbi.nlm.nih.gov/pubmed/27534620
http://dx.doi.org/10.1186/s12874-016-0205-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4989379/
https://www.ncbi.nlm.nih.gov/pubmed/27534620
http://dx.doi.org/10.1186/s12874-016-0205-4

Ejemplares similares